denoting or relating to a biopharmaceutical drug designed to have active properties similar to those of a drug that has previously been licensed

the company is developing biosimilar versions of some of the major immunology and oncology drugs

a biosimilar drug

copycat drug makers use an innovator's research data to make biosimilars